Scientist II, CMC Antibody Development, Biologics

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit  neurocrine.com , and follow the company on  LinkedIn ,  X , Facebook and YouTube . ( *in collaboration with AbbVie ) About the Role: Represent Product Development on CMC project teams across all stages of development, from early discovery through commercial launch. Provide formulation and analytical expertise to support multiple preclinical and clinical programs. Design and execute preformulation and formulation development studies to enable product advancement, delivering phase-appropriate, safe, and therapeutically effective dosage forms that support regulatory progression and commercialization. Lead the development and optimization of manufacturing processes for a variety of pharmaceutical compounds, applying a deep understanding of material properties, operating parameters, and their impact on critical quality attributes to ensure robust performance throughout development, scale-up, and commercial readiness. _ Your Contributions (include, but are not limited to): Collaborate cross-functionally with Research/Discovery, Chemical Development, Analytical Development, Clinical, Quality, Regulatory, Supply Chain, and external CDMO partners to advance programs from early discovery through commercial launch, ensuring effective communication and alignment across departments and organizations Apply first principles of formulation and process science to design and execute preformulation and formulation development studies to deliver phase-appropriate dosage forms aligned with target product profiles Plan and execute studies using Quality by Design (QbD) principles, including Design of Experiments (DOE), to optimize formulations and manufacturing processes across development stages Prepare, evaluate, and optimize formulations for preclinical and clinical use and determine downstream manufacturability risks Lead pilot-scale and commercial process scale-up activities in support of scale-up and technical transfer activities Represent the company during on-site CDMO manufacturing campaigns (“person-in-plant”), ensuring adherence to partner SOPs and effective technical communication Research, evaluate, source, procure, install, qualify, operate, and maintain instrumentation and emerging formulation technologies to support preformulation, material science, and process development activities Prepare, review, and maintain pharmaceutical development documentation including laboratory notebooks (per SOP), protocols, reports, specifications, batch records, and CMC regulatory submissions, ensuring scientific integrity and compliance with cGMP and global regulatory requirements Maintain organized documentation repositories for formulation and material characterization data, development reports, and process knowledge to support knowledge management and regulatory readiness Lead or participate in periodic project team meetings, clearly communicating progress, risks, timelines, and resource needs to stakeholders and